title: [Likopid in complex treatment of oral dysbiosis].
abstract: The aim of the study was to assess likopid effectiveness in complex treatment of oral dysbiosis. The study included 76 patients: 23 patients receiving antifungal and antimicrobial treatment, eubiotics and bacteriophages and 53 patients in which the above mentioned therapy was combined with licopid as immunocorrective agent. Laser flow cytometry was used to examine oral fluid bacteriostatic properties. The results of the study confirm licopid to be useful for complex treatment of oral dysbiosis.
authors.forename: O F
authors.initials: OF
authors.lastname: Rabinovich
authors.forename: I M
authors.initials: IM
authors.lastname: Rabinovich
authors.forename: E S
authors.initials: ES
authors.lastname: Abramova
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D018928:Immunity, Mucosal; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000188:drug therapy* / Q000276:immunology* / Q000382:microbiology; D009061:Mouth Mucosa / Q000276:immunology* / Q000382:microbiology*; D012463:Saliva / Q000382:microbiology
chemical_list: C089161:glikopin; D000119:Acetylmuramyl-Alanyl-Isoglutamine